These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 25815325)
21. Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol in Patients Receiving Maintenance Hemodialysis. Thadhani RI; Rosen S; Ofsthun NJ; Usvyat LA; Dalrymple LS; Maddux FW; Hymes JL Clin J Am Soc Nephrol; 2020 Mar; 15(3):384-391. PubMed ID: 32111702 [TBL] [Abstract][Full Text] [Related]
22. Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients. Dusilová-Sulková S; Šafránek R; Vávrová J; Horáček J; Pavlíková L; Palička V Int Urol Nephrol; 2015 Jan; 47(1):169-76. PubMed ID: 25262147 [TBL] [Abstract][Full Text] [Related]
23. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation. Petkovich M; Melnick J; White J; Tabash S; Strugnell S; Bishop CW J Steroid Biochem Mol Biol; 2015 Apr; 148():283-9. PubMed ID: 25446887 [TBL] [Abstract][Full Text] [Related]
24. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652 [TBL] [Abstract][Full Text] [Related]
25. Vitamin D Metabolites and Their Association with Calcium, Phosphorus, and PTH Concentrations, Severity of Illness, and Mortality in Hospitalized Equine Neonates. Kamr AM; Dembek KA; Reed SM; Slovis NM; Zaghawa AA; Rosol TJ; Toribio RE PLoS One; 2015; 10(6):e0127684. PubMed ID: 26046642 [TBL] [Abstract][Full Text] [Related]
26. Serum Parathyroid Hormone Responses to Vitamin D Supplementation in Overweight/Obese Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Lotito A; Teramoto M; Cheung M; Becker K; Sukumar D Nutrients; 2017 Mar; 9(3):. PubMed ID: 28272298 [TBL] [Abstract][Full Text] [Related]
27. All 25-hydroxyvitamin D-deficient Indian postmenopausal women do not have secondary hyperparathyroidism. Dixit V; Tripathi RL; Dhanwal DK Arch Osteoporos; 2018 May; 13(1):62. PubMed ID: 29806069 [TBL] [Abstract][Full Text] [Related]
28. Hip fracture patients in India have vitamin D deficiency and secondary hyperparathyroidism. Dhanwal DK; Sahoo S; Gautam VK; Saha R Osteoporos Int; 2013 Feb; 24(2):553-7. PubMed ID: 22543576 [TBL] [Abstract][Full Text] [Related]
29. Postpartum vitamin D insufficiency and secondary hyperparathyroidism in healthy Danish women. Møller UK; Ramlau-Hansen CH; Rejnmark L; Heickendorff L; Henriksen TB; Mosekilde L Eur J Clin Nutr; 2006 Oct; 60(10):1214-21. PubMed ID: 16721399 [TBL] [Abstract][Full Text] [Related]
30. Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23. Mazzaferro S; Pasquali M; Pugliese F; Citterio F; Gargiulo A; Rotondi S; Tartaglione L; Conte C; Pirrò G; Taggi F J Nephrol; 2012; 25(6):1108-18. PubMed ID: 22383345 [TBL] [Abstract][Full Text] [Related]
31. DOES VITAMIN D METABOLITE MEASUREMENT HELP PREDICT 25(OH)D CHANGE FOLLOWING VITAMIN D SUPPLEMENTATION? Binkley N; Borchardt G; Siglinsky E; Krueger D Endocr Pract; 2017 Apr; 23(4):432-441. PubMed ID: 28095046 [TBL] [Abstract][Full Text] [Related]
32. Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D. Goswami R; Gupta N; Ray D; Singh N; Tomar N Br J Nutr; 2008 Sep; 100(3):526-9. PubMed ID: 18252022 [TBL] [Abstract][Full Text] [Related]
33. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Zisman AL; Hristova M; Ho LT; Sprague SM Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573 [TBL] [Abstract][Full Text] [Related]
34. Normocalcemia without hyperparathyroidism in vitamin D-deficient rats. Kollenkirchen U; Fox J; Walters MR J Bone Miner Res; 1991 Mar; 6(3):273-8. PubMed ID: 2035354 [TBL] [Abstract][Full Text] [Related]
36. Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. Burnett-Bowie SA; Leder BZ; Henao MP; Baldwin CM; Hayden DL; Finkelstein JS Clin J Am Soc Nephrol; 2012 Apr; 7(4):624-31. PubMed ID: 22300739 [TBL] [Abstract][Full Text] [Related]
37. Serum 25-hydroxyvitamin D, calcium and parathyroid hormone levels in Native and European populations in Greenland. Andersen S; Noahsen P; Rex KF; Fleischer I; Albertsen N; Jørgensen ME; Schæbel LK; Laursen MB Br J Nutr; 2018 Feb; 119(4):391-397. PubMed ID: 29498343 [TBL] [Abstract][Full Text] [Related]
38. Interventions for metabolic bone disease in children with chronic kidney disease. Hahn D; Hodson EM; Craig JC Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008327. PubMed ID: 26561037 [TBL] [Abstract][Full Text] [Related]
39. Influence of daily regimen calcium and vitamin D supplementation on parathyroid hormone secretion. Reginster JY; Zegels B; Lejeune E; Micheletti MC; Kvsaz A; Seidel L; Sarlet N Calcif Tissue Int; 2002 Feb; 70(2):78-82. PubMed ID: 11870412 [TBL] [Abstract][Full Text] [Related]
40. Comparative 25-OH-vitamin D level in institutionalized women older than 65 years from two cities in Spain and Argentina having a similar solar radiation index. Portela ML; Mónico A; Barahona A; Dupraz H; Sol Gonzales-Chaves MM; Zeni SN Nutrition; 2010 Mar; 26(3):283-9. PubMed ID: 19819110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]